- Home
- JILL vs RNAC Comparison
JILL vs RNAC Comparison
Compare JILL & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- RNAC
- Stock Information
- Founded
- JILL 1959
- RNAC 2007
- Country
- JILL United States
- RNAC United States
- Employees
- JILL N/A
- RNAC N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- JILL Consumer Discretionary
- RNAC Health Care
- Exchange
- JILL Nasdaq
- RNAC Nasdaq
- Market Cap
- JILL 233.1M
- RNAC 264.7M
- IPO Year
- JILL 2017
- RNAC 2016
- Fundamental
- Price
- JILL $16.06
- RNAC $9.16
- Analyst Decision
- JILL Strong Buy
- RNAC Strong Buy
- Analyst Count
- JILL 5
- RNAC 7
- Target Price
- JILL $33.40
- RNAC $41.00
- AVG Volume (30 Days)
- JILL 78.7K
- RNAC 70.9K
- Earning Date
- JILL 06-06-2025
- RNAC 05-08-2025
- Dividend Yield
- JILL 1.37%
- RNAC N/A
- EPS Growth
- JILL 3.98
- RNAC N/A
- EPS
- JILL 2.61
- RNAC N/A
- Revenue
- JILL $610,857,000.00
- RNAC $34,173,000.00
- Revenue This Year
- JILL $3.91
- RNAC N/A
- Revenue Next Year
- JILL $3.30
- RNAC N/A
- P/E Ratio
- JILL $6.16
- RNAC N/A
- Revenue Growth
- JILL 0.46
- RNAC 31.91
- 52 Week Low
- JILL $14.37
- RNAC $8.85
- 52 Week High
- JILL $40.61
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- JILL 45.14
- RNAC 35.10
- Support Level
- JILL $16.65
- RNAC $9.91
- Resistance Level
- JILL $18.37
- RNAC $10.43
- Average True Range (ATR)
- JILL 0.65
- RNAC 0.84
- MACD
- JILL 0.08
- RNAC -0.05
- Stochastic Oscillator
- JILL 38.07
- RNAC 4.58
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.